Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Heated Lidocaine/Tetracaine Patch
- Registration Number
- NCT01688518
- Lead Sponsor
- CRI Lifetree
- Brief Summary
This will be a randomized, single-blind, active-controlled, two-period crossover study in adult volunteers to compare the duration and depth of anesthesia between Synera® and Lidoderm® patches when applied for 30 minutes and 4 hours. The study will include a Screening Visit, two Treatment Periods, and a Follow-Up Phone Contact.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Synera® for 30min & Lidoderm® for 4 hours Heated Lidocaine/Tetracaine Patch Heated Lidocaine/Tetracaine (Synera®)applied to one forearm for either 30 minutes or 4 hours and a 5% Lidocaine (Lidoderm®) patch applied to the alternate forearm for the alternate time period. Lidoderm® for 30min & Synera® for 4 hours Heated Lidocaine/Tetracaine Patch Heated Lidocaine/Tetracaine (Synera®)applied to one forearm for either 30 minutes or 4 hours and a 5% Lidocaine (Lidoderm®) patch applied to the alternate forearm for the alternate time period. Lidoderm® for 30min & Synera® for 4 hours 5% Lidocaine Patch Heated Lidocaine/Tetracaine (Synera®)applied to one forearm for either 30 minutes or 4 hours and a 5% Lidocaine (Lidoderm®) patch applied to the alternate forearm for the alternate time period. Synera® for 30min & Lidoderm® for 4 hours 5% Lidocaine Patch Heated Lidocaine/Tetracaine (Synera®)applied to one forearm for either 30 minutes or 4 hours and a 5% Lidocaine (Lidoderm®) patch applied to the alternate forearm for the alternate time period.
- Primary Outcome Measures
Name Time Method Depth of Anesthesia measured in mm via insertion of 21-gauge needle into the skin. Approximately 5 months
- Secondary Outcome Measures
Name Time Method Duration of Anesthesia measured in sensory presence, absence, and thermal thresholds. Approximately 5 months
Trial Locations
- Locations (1)
Lifetree Clinical Research
🇺🇸Salt Lake City, Utah, United States